Rituxan Hycela contains hyaluronidase human, an enzyme that helps with the subcutaneous delivery of Rituxan's active ingredient, rituximab, allowing for faster administration compared with intravenous Rituxan.
The Preserving Patient Access to Compounded Medications Act of 2017 would clarify the Drug Quality and Security Act in a way that would align the statute with congressional intent to balance the issues of public safety and patient access.
The company said that it’s expecting a launch in the second-half of 2017, and that it has already submitted an application to the FDA for a junior version of Symjepi.
The National Community Pharmacists Association shared with the Centers for Medicare and Medicaid Service a list of provisions it hopes will be included in the final rule for managed care organizations.
Day on the Hill attendees spend a full day conducting face-to-face meetings with Congressional offices.
In PrescribeWellness’ 2017 Vaccination and Preventive Care Study, 55% of survey respondents said they prefer their pharmacy to their physician’s office as the place to get vaccinated.
The Council for Responsible Nutrition’s Supplement OWL is an online product registry that serves as resource for regulators, retailers and the industry, and can be accessed by anyone.